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Abstract
We evaluated the prevalence of low bone mineral density (BMD) and
osteoporotic fractures in kidney transplantation (KT) patients and
determined risk factors associated with osteoporotic fractures. The
study was conducted on 191 patients (94 men and 97 women) with
first KT for 3 years or more presenting stable and preserved renal
function (serum creatinine levels lower than 2.5 mg/dl). KT patients
were on immunosuppressive therapy and the cumulative doses of
these drugs were also evaluated. BMD was determined by dual-energy
X-ray absorptiometry at multiple sites (spine, femur and total body).
Quantitative ultrasound of the calcaneus (broadband ultrasound at-
tenuation, speed of sound, and stiffness index, SI) was also performed.
Twenty-four percent (46) of all patients had either vertebral (29/46) or
appendicular (17/46) fractures. We found osteoporosis and osteopenia
in 8.5-13.4 and 30.9-35.1% of KT patients, respectively. Women had
more fractures than men. In women, prevalent fractures were associ-
ated with diabetes mellitus [OR = 11.5, 95% CI (2.4-55.7)], time since
menopause [OR = 3.7, 95% CI (1.2-11.9)], femoral neck BMD [OR =
1.99, 95% CI (1.4-2.8)], cumulative dose of steroids [OR = 1.1, 95%
CI (1.02-1.12)] and low SI [OR = 1.1, 95% CI (1.0-1.2)]. In men,
fractures were associated with lower lumbar spine BMD [OR = 1.75,
95% CI (1.1-2.7)], lower SI [OR = 1.1, 95% CI (1.03-1.13)], duration
of dialysis [OR = 1.3, 95% CI (1.13-2.7)], and lower body mass index
[OR = 1.24, 95% CI (1.1-1.4). Our results demonstrate high preva-
lence of low BMD and osteoporotic fractures in patients receiving a
successful kidney transplant and indicate the need for specific inter-
vention to prevent osteoporosis in this population.
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Introduction
End-stage renal disease (ESRD) is asso-
ciated with multiple skeletal and mineral
metabolism disorders, leading to bone dis-
ease generically called “renal osteodystro-
phy” (1). Many mechanisms are involved in
its pathophysiology including calcitriol defi-
ciency, hypocalcemia, hyperphosphatemia,
secondary hyperparathyroidism, metabolic
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acidosis, uremia, and aluminum deposition
(2). Age, gender, duration of dialysis, low
calcium intake, and drugs such as phosphate
binders may also play an important role in
bone disease associated with ESRD (1,2).
Kidney transplantation (KT) is the treat-
ment of choice for ESRD and its demand has
grown tremendously due to the small num-
ber of short-term complications, mainly re-
jection episodes, and the increased long-
term survival rates and quality of life when
compared with patients treated with hemo-
dialysis. Although most metabolic distur-
bances are reversible after transplantation,
restoration of glomerular filtration and im-
provement of calcitriol production do not
reverse renal bone disease. Many studies
have shown that bone disease may persist
during the first years following transplanta-
tion or even become worse due, in part, to
the need for immunosuppressive therapy such
as glucocorticosteroid, cyclosporine A and
tacrolimus (FK506), which are important to
prevent transplant rejection (3-5). Cyclo-
sporine A and tacrolimus are relatively new
immunosuppressive agents that, despite their
well-documented steroid-sparing effect, are
associated with several clinical complica-
tions. Particularly, the musculoskeletal sys-
tem is often affected (6).
KT affects bone integrity and increases
the risk of fragility fractures. However, not
every patient displays sustained bone loss
after KT. Due to post-transplantation bone
disease, a rapid reduction of bone mineral
density (BMD) develops that can exceed
10% in the first 12 months. Subsequently,
the bone loss slows down or even a second-
ary increase occurs (7). Three patterns of
BMD profiles have been observed after trans-
plantation: a) steady decrease, b) decrease
over 6 months and partial correction, and c)
decrease over 6 months and total correction.
The most important and disabling clini-
cal outcome of post-transplantation bone dis-
ease is fragility fracture (8-12). KT is associ-
ated with early rapid bone loss and subse-
quent sustained bone loss, consequently in-
creasing fracture risk (3,4,13). Low BMD is
one of the most important risk factors for
fractures (14). However, fractures have been
documented to occur not only in patients
with low BMD but also in patients with
normal BMD (8), suggesting that other fac-
tors may also play an important role to deter-
mine fractures in this population. Besides
BMD, bone architecture, geometrical prop-
erties of the bone and risk of falls are also
significant determinants of fracture risk. Age,
ethnic origin, history of previous fracture,
female sex and low weight, important risk
factors for fracture previously reported in
the general population (15), have also been
observed in ESRD patients (16), and re-
cently in KT patients (17).
Bone architecture can theoretically be
assessed by quantitative ultrasound (QUS).
QUS is a new, simple, portable, inexpen-
sive, radiation-free method that evaluates
bone structure and predicts fracture inde-
pendently of BMD. It has been suggested as
an alternative approach to BMD measure-
ment to assess skeletal fragility and bone
quality (18). Only a few studies have ana-
lyzed QUS parameters in KT patients and its
usefulness in this set of patients has not been
established.
In the present study, we evaluated the
prevalence of low trauma fractures and low
bone mass in KT patients presenting stable
and preserved renal function. A search was
also made for clinical risk factors potentially
associated with osteoporotic fractures in this
population. We describe here important clini-
cal and densitometric determinants of frac-
ture risk in KT recipients with preserved
renal function.
Patients and Methods
Patients
Five hundred KT patients were selected
from our transplant unit database in May
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2000. These patients were Brazilian men
and women living in the São Paulo metro-
politan area, Brazil, under regular follow-up
at the Renal Transplant Center of São Paulo
Hospital, São Paulo, SP, Brazil. After ap-
proval from the local Ethics Committee, 207
patients were invited by telephone to partici-
pate in the present study. Only first-KT re-
cipients were selected. Patients were se-
lected at random from those with a kidney
transplant performed at least three years be-
fore, and stable graft function (serum creati-
nine 2.5 mg/dL or less). All patients gave
written informed consent to participate. Of a
total of 207 patients invited, 191 concluded
the study. Six patients did not accept to
participate in the study protocol and 10 oth-
ers did not attend the first appointment. Mean
age was 44.8 ± 0.8 years and average time
since transplantation was 87 ± 3.7 months.
The cause of renal failure was unknown in
80 patients (41.9%) whereas chronic glo-
merulonephritis, hypertension, diabetes mel-
litus, polycystic kidney disease, and obstruc-
tive nephropathy were responsible for renal
failure in 65 (34%), 18 (9.4%), 11 (5.7%), 5
(2.6%), and 4 (2.1%) cases, respectively.
Other causes of renal failure were observed
in 8 patients.
Patients were 94 males (20 of them had
diabetes mellitus) and 97 females (30 of
them were postmenopausal and 14 had dia-
betes mellitus). The medical charts of all
patients were analyzed and the following
information was obtained: demographic data,
duration of pretransplant dialysis, time since
transplantation, serum creatinine, value of
glomerular function predicted by the equa-
tion of Cocroft and Gault, and cumulative
drug dosage (steroids, cyclosporine A and
azathioprine).
Exclusion criteria were prolonged im-
mobilization, systemic illness or malignancy,
as well as the use of drugs that affect bone
metabolism (bisphosphonates, calcitonin,
fluoride, selective estrogen receptor modu-
lators, etc.), except immunosuppressive
agents and corticosteroids. Calcium supple-
ment use and hormone replacement therapy
were not exclusion criteria for this study.
Fracture ascertainment
Patients were asked about symptomatic
low-trauma fractures during the interview.
None of them had symptomatic vertebral
fractures. Traumatic fracture was excluded.
Plain radiographs of the thoracic and lumbar
spine were obtained for all patients using
standard protocols to determine prevalent
vertebral deformities. Vertebral deformity
was defined by a quantitative method ac-
cording to Eastell’s criteria (19).
Bone mineral density measurements
Dual-energy X-ray absorptiometry was
performed in all patients using a Lunar DPX
device (Lunar Corp., Madison, WI, USA)
and lumbar spine (LS) and femoral neck
(FN) BMD was measured. These measure-
ments were performed at the Osteoporosis
Unit, Rheumatology Division, São Paulo
Hospital, over a 5-month period. Daily cali-
bration measurements using a phantom were
performed according to manufacturer instruc-
tions. Coefficients of variation for BMD
measurements were 1.9% for LS and 3.6%
for FN. Prevalence of low bone mass in men
and women was defined according to the
World Health Organization (WHO) recom-
mendations (20).
Quantitative ultrasound measurements
Bilateral heel QUS measurements were
carried out using the Achilles + equipment
(Lunar). During the passage of the ultra-
sound wave through the bone, its character-
istic frequency spectrum is altered. These
changes reflect the QUS parameters ana-
lyzed, i.e., broadband ultrasound attenua-
tion (BUA), speed of sound (SOS) and stiff-
ness index (SI). SI is a mathematical combi-
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nation of BUA and SOS values [SI = 0.67 x
BUA + 0.28 x SOS - 420]. T and Z scores for
SI were calculated by comparison to a sys-
tem-inherent white reference population for
the same gender and age. The QUS normal
reference curve for the Brazilian population
is not significantly different from the Ameri-
can reference range (21), and so the latter
was used in our study. The inter-foot coeffi-
cient of variation for QUS parameters was
investigated and no statistically significant
difference was found between left and right
calcaneus measurements. For logistic regres-
sion analysis, right heel measurements were
used. Precision errors determined as root
mean squared coefficient of variation were
1.01% for BUA, 0.23% for SOS and 1.25%
for SI (21).
Statistical analysis
Data are reported as means ± SEM. The
SEM was chosen because it represents 68%
of the population and ranges are presented
when needed. The significance of the differ-
ences between groups (men versus women,
men with fractures versus men with no frac-
tures, women with fractures versus women
with no fractures) was tested by the unpaired
Student t-test, chi-square test or Pearson’s
correlation analysis when appropriate. Lo-
gistic regression analysis was performed to
determine the factors that were better associ-
ated with fractures in our population. Since
gender plays a critical role in bone mass and
metabolism determination, separate analy-
ses were performed for males and females.
Variables significantly associated with frac-
ture by chi-square analysis were tested by
logistic regression analysis. For all analyses,
the level of significance was set at P < 0.05.
Results
Characteristics of the kidney transplantation
population
Table 1 shows descriptive characteristics
of KT patients according to gender. Ninety-
seven patients were females and 94 were
males (mean age: 43.2 ± 1.0 and 46.6 ± 1.2
years, respectively). Males were significant-
ly older, heavier and taller than females (P <
0.05). Since anthropomorphic characteris-
Table 1. Anthropomorphic and clinical data for 191 kidney transplant recipients according to gender.
Total (N = 191) Males (N = 94) Females (N = 97)
Age (years) 44.8 ± 0.78 (20-70) 46.6 ± 1.16 (20-70) 43.2 ± 1* (23-68)
Weight (kg) 68.62 ± 1.11 (42-126) 73.87 ± 1.46 (47-120) 63.53 ± 1.48* (42-126)
Height (m) 1.63 ± 0.002 (1.39-1.85) 1.66 ± 0.007 (1.41-1.85) 1.54 ± 0.007* (1.39-1.68)
BMI (kg/m2) 26.55 ± 0.38 (17.5-49.8) 26.61 ± 0.47 (17-44) 26.5 ± 0.57 (18-49)
Duration of dialysis (months) 46.48 ± 3.03 (3-204) 41.74 ± 3.79 (5-204) 51.08 ± 4.66 (3-193)
Time since transplantation (months) 86.96 ± 3.71 (36-231) 91.68 ± 5.51 (36-231) 82.39 ± 4.97 (36-231)
Creatinine (mg/dL) 1.62 ± 0.03 (0.9-2.5) 1.67 ± 0.03 (1-2.5) 1.57 ± 0.04 (0.9-2.5)
Cumulative dose of steroids (g) 29.93 ± 1.47 (0-114.33) 33.73 ± 2.41 (0-114) 26.25 ± 1.64* (3-91)
Cumulative dose of cyclosporin (g) 482.8 ± 26.4 (0-1516.4) 507.48 ± 42.5 (0-1516) 460.78 ± 31.96 (0-1158)
Cumulative dose of azathioprine (g) 224.2 ± 15.32 (0-1087.9) 259.9 ± 24.95 (0-1087) 191.1 ± 17.59* (0-858)
Data are reported as means ± SEM with range within parentheses. BMI = body mass index.
*P < 0.05 compared to males (Student t-test).
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tics and bone measurements were also statis-
tically different between men and women
(Tables 1 and 2), males and females were
evaluated separately. Diabetes mellitus was
present in 34 patients (20 males and 14
females) and 30 of 97 women were post-
menopausal. None of the postmenopausal
women were taking hormone replacement
therapy.
The transplanted kidney was from a liv-
ing donor in 104 patients and from a cadaver
in 87 patients. Most of the living transplants
were from genetically related donors (94.2%)
while 5.8% were from non-genetically re-
lated donors. Most of the non-genetically
related transplants were from spouses
(66.7%).
Anthropomorphic data, clinical aspects
and immunosuppressive therapy used for
patients with or without fractures after KT,
according to gender, are shown in Table 3.
KT female patients with fractures were sig-
nificantly older and had used significantly
higher cumulative doses of steroids than
women with no fracture. KT men with frac-
tures were significantly thinner and shorter
Table 3. Anthropomorphic parameters and clinical data for 191 male and female kidney transplant recipients according to
fracture status.
Men Women
Fracture (N = 20) Non-fracture (N = 74) Fracture (N = 26) Non-fracture (N = 71)
Age (years) 47.15 ± 2.44 46.46 ± 1.33 46.69 ± 1.93 41.93 ± 1.13*
Weight (kg) 64.80 ± 2.41 76.32 ± 1.63* 66.88 ± 3.05 62.31 ± 1.69
Height (m) 1.61 ± 0.011 1.67 ± 0.008* 1.54 ± 0.011 1.54 ± 0.008
BMI (kg/m2) 24.75 ± 1.01 27.15 ± 0.52* 28.16 ± 1.23 25.89 ± 0.63
Creatinine (mg/dL) 1.77 ± 0.09 1.64 ± 0.03 1.67 ± 0.08 1.53 ± 0.04
Duration of dialysis (months) 61.10 ± 11.24 36.51 ± 3.55* 55.80 ± 9.11 49.35 ± 5.44
Time since transplantation (months) 83 ± 12.4 94.07 ± 6.17 93.65 ± 11.38 78.26 ± 5.33
Cumulative dose of steroids (g) 32.04 ± 5.4 34.19 ± 2.71 33.15 ± 3.99 23.73 ± 1.62*
Cumulative dose of cyclosporin A (g) 351.81 ± 65.38 549.56 ± 50.09* 546.61 ± 64.12 429.35 ± 36.39
Cumulative dose of azathioprine (g) 227.19 ± 57.24 268.73 ± 27.78 226.30 ± 44.59 178.33 ± 17.64
Data are reported as means ± SEM. BMI = body mass index.
*P < 0.05 compared to same sex with fracture (Student t-test).
Table 2. Bone mineral density (BMD) and quantitative ultrasound (QUS) parameters for 191 kidney transplant recipients
according to gender.
Total (N = 191) Men (N = 94) Women (N = 97)
LS BMD (g/cm2) 1.119 ± 0.013 (0.710-1.920) 1.096 ± 0.017 (0.710-1.480) 1.141 ± 0.021 (0.740-1.920)
FN BMD (g/cm2) 0.886 ± 0.014 (0.600-1.425) 0.919 ± 0.016 (0.900-1.262) 0.864 ± 0.016* (0.600-1.425)
QUS
Right heel
BUA (dB/MHz) 109.1 ± 0.81 (64-140) 110.66 ± 1.21 (78-140) 107.59 ± 1.08* (64-128)
SOS (m/s) 1542 ± 2.52 (1457-1652) 1531 ± 11.62 (1457-1652) 1542 ± 3.40 (473-1647)
SI (%) 84.55 ± 1.11 (36-127) 85.55 ± 1.70 (44-127) 83.58 ± 1.47 (36-119)
Left heel
BUA (dB/MHz) 108.1 ± 0.74 (62-140) 109.77 ± 1.20 (62-140) 106.66 ± 0.89* (88-136)
SOS (m/s) 1540.61 ± 2.61 (1404-1729) 1541.74 ± 3.44 (1471-1627) 1540 ± 3.95 (1404-1729)
SI (%) 83.48 ± 1.09 (38-150) 84.76 ± 1.59 (55-121) 82.32 ± 1.51 (38-150)
Data are reported as means ± SEM with range within parentheses. LS = lumbar spine; FN = femoral neck; BUA = broadband
ultrasound attenuation; SOS = speed of sound; SI = stiffness index.
*P ≤ 0.05 compared to males (Student t-test).
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and had lower BMI values than those with-
out fractures. On the other hand, no statisti-
cally significant difference in age was found
in this subset of the KT population studied.
Significantly longer duration of pre-KT di-
alysis was observed in KT men with frac-
tures compared to those without fractures (P
< 0.05).
LS and FN BMD values were signifi-
cantly lower in KT male and female patients
with fractures compared to controls with no
fractures (Table 4). Even after adjustments
for age and menopausal status, BMD values
were still significantly lower in women with
fractures than in women with no fractures.
QUS values tended to be lower in men and
women with fractures compared to their non-
fracture controls, although the difference
was not statistically significant (Table 4).
Bone mineral density and quantitative
ultrasound measurements
BMD and QUS measurements for KT
patients are shown in Table 2. Male patients
had significantly higher FN BMD and BUA
values than female patients. When BMD
was classified according to the WHO crite-
ria for skeletal fragility and risk of fracture,
we found osteoporosis in 8.5-13.4% of KT
patients and osteopenia in 30.9-35.1%, de-
pending on gender or skeletal site examined.
The prevalence of osteoporosis and osteope-
nia at the FN and LS did not differ signifi-
cantly between men and women (Table 5).
Fracture data
Table 6 shows the prevalence of fragility
fracture in our population. Forty-six KT pa-
tients (24%) presented low-impact fractures
in our survey (20 men and 26 women, of
whom 14 were postmenopausal). None of
the postmenopausal women were under hor-
mone replacement therapy. A history of pe-
ripheral fracture after low trauma was ob-
served in 14 patients (mean time from trauma
to KT: 8 years; range: 6 months to 12 years).
Vertebral fractures were found in 29 patients
(63% of the total cases with fractures, 17
men and 12 women). Three patients had
peripheral and vertebral fractures simulta-
neously.
Diabetes mellitus was observed in 9 fe-
male KT patients with vertebral (N = 3) or
peripheral (N = 6) fractures, but only in 3
Table 4. Bone mineral density (BMD) and quantitative ultrasound (QUS) parameters for 191 kidney transplant
recipients according to fracture status and gender.
Men Women
Fracture (N = 20) Non-fracture (N = 74) Fracture (N = 26) Non-fracture (N = 71)
LS BMD (g/cm2) 0.983 ± 0.039 1.128 ± 0.017* 1.059 ± 0.03 1.171 ± 0.025*
FN BMD (g/cm2) 0.849 ± 0.029 0.938 ± 0.018* 0.808 ± 0.025 0.896 ± 0.018*
QUS
Right heel
BUA (dB/MHz) 107.95 ± 2.90 111.4 ± 1.31 107.19 ± 2.13 107.74 ± 1.25
SOS (m/s) 1532 ± 8.13 1530 ± 14.67 1533 ± 7.42 1546 ± 3.71
SI (%) 81.35 ± 3.82 86.71 ± 1.89 80.5 ± 3.16 84.72 ± 1.64
Left heel
BUA (dB/MHz) 107.10 ± 2.12 110.50 ± 1.41 106.26 ± 2.06 106.81 ± 0.96
SOS (m/s) 1531.55 ± 6.1 1544.53 ± 4.01 1530.46 ± 7.08 1544.04 ± 4.69
SI (%) 80.15 ± 2.86 86.02 ± 1.87 79.3 ± 3.19 83.44 ± 1.69
Data are reported as means ± SEM. LS = lumbar spine; FN = femoral neck; BUA = broadband ultrasound
attenuation; SOS = speed of sound; SI = stiffness index.
*P < 0.05 compared to same sex with fracture (Student t-test).
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males with fracture (vertebral = 2; non-ver-
tebral = 1).
Risk factors for fracture
Backward conditional logistic regression
analysis was performed including all vari-
ables that showed significance in the chi-
squared analysis in order to identify poten-
tial risk factors for fractures in this popula-
tion. Again, men and women were analyzed
separately. Renal function assessed by creati-
nine levels and predicted creatinine clear-
ance was not associated with BMD meas-
urements or with the presence of fractures.
As shown in Table 7, presence of diabetes
mellitus [OR = 11.5, 95% CI (2.4-55.7)],
menopausal status [OR = 3.7, 95% CI (1.2-
11.9)] and FN BMD [OR = 1.99, 95% CI
(1.4-2.8)] were the most important determi-
nants of fracture risk in KT female patients.
Less important but still significant risk fac-
tors for fracture in KT women were cumula-
tive dose of steroids [OR = 1.1, 95% CI
(1.02-1.12)] and low SI [OR = 1.1, 95% CI
(1.0-1.2)]. Lower LS BMD [OR = 1.75, 95%
CI (1.1-2.7)], lower SI [OR = 1.1, 95% CI
(1.03-1.13)], longer duration of dialysis [OR
= 1.3, 95% CI (1.13- 2.7)], and lower BMI
values [OR = 1.24, 95% CI (1.1-1.4) were
the factors that associated best with the pres-
ence of fractures in KT men.
Discussion
KT is a successful treatment for ESRD
and results in better quality of life. In Brazil,
the rate of KT reaches 3000 per year (22)
with increasing long-term survival rates prob-
ably associated with the routine use of
cyclophilin-binding agents (5). On the other
hand, the use of immunosuppressants, espe-
cially glucocorticosteroids, causes multiple
skeletal complications, including osteoporo-
sis and increased fracture risk.
The current study was designed to esti-
mate the prevalence of low-trauma fracture
Table 5. Prevalence of low bone mass (osteopenia and osteoporosis) in 191 kidney
transplant recipients according to gender and skeletal site.
Skeletal site Normal Osteopenia Osteoporosis
Lumbar spine
Men 52 (55.3%) 30 (31.9%) 12 (12.8%)
Women 55 (56.7%) 32 (32.9%) 10 (10.3%)
Femoral neck
Men 53 (56.4%) 33 (35.1%) 8 (8.5%)
Women 54 (55.6%) 30 (30.9%) 13 (13.4%)
LS + FN
Men 42 (44.6%) 17 (18%) 2 (2.1%)
Women 44 (45.3%) 16 (16.4%) 4 (4.1%)
Data are reported as number and percent. LS = lumbar spine; FN = femoral neck.
Table 6. Prevalence of fractures in 191 kidney transplant recipients according to
gender and skeletal site.
Male Male Female Total
Vertebral fracture 17 (85%) 12 (46%) 29 (63%)
Non-vertebral fracture 2 (10%) 12 (46%) 14 (30.4%)
Vertebral + non-vertebral fractures 1 (5%) 2 (7.7%) 3 (6.5%)
Total 20 (100%) 26 (100%) 46 (100%)
Data are reported as number and percent.
Table 7. Logistic regression analysis and age-adjusted odds ratio for factors associ-
ated with higher fracture risk for 191 kidney transplant recipients according to gender.
OR (95% CI)
Women
Diabetes mellitus 11.5 (2.4-55.7)
Menopausal status 3.7 (1.2-11.9)
Femoral neck BMD 1.99 (1.4-2.8)
Stiffness index 1.1 (1.0-1.2)
Cumulative dose of steroids 1.1 (1.02-1.12)
Men
Lumbar spine BMD 1.75 (1.1-2.7)
Stiffness index 1.1 (1.03-1.13)
Dialysis time 1.3 (1.13-2.7)
Body mass index 1.24 (1.1-1.4)
Cumulative dose of cyclosporin A 0.4 (0.3-0.8)
BMD = bone mineral density; OR = odds ratio; 95% CI = 95% confidence interval.
P < 0.05 for all factors.
and osteoporosis in KT long-term recipi-
ents. Prevalent vertebral deformity and/or
previous low-trauma fracture were found in
46 (of 191) KT patients (24%), with the
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difference between genders being not statis-
tically significant. These data show that KT
patients presented significantly higher frac-
ture prevalence than that observed for the
general population. Others have found simi-
lar fracture rates in KT patients (0-38.5%)
(8-12,23-25). Some of this variability in frac-
ture prevalence among KT patients might be
related to the design of the study, the popu-
lation assessed and the criteria used to define
fracture, particularly vertebral deformity.
Vertebral deformities were observed in
29 of 46 patients with fractures (63% of the
total number of fractures). This observation
is consistent with some other studies (8,10,23-
25) that have demonstrated a higher preva-
lence of vertebral than non-vertebral frac-
tures in this set of patients. Patel et al. (25),
using a different method to identify verte-
bral fracture, reported a prevalence of verte-
bral deformities in KT patients similar to
ours, while other investigators have observed
a lower prevalence of vertebral fractures
than that described in the present study
(9,26,27). These conflicting findings prob-
ably reflect methodological differences (in-
clusion criteria, selection bias) and manage-
ment discrepancies (dialysis and transplan-
tation) among centers. Moreover, ethnic and
geographic factors may also play an impor-
tant role in low-trauma fracture occurrence.
Melton III et al. (28) observed that the preva-
lence of vertebral fractures ranges from 8 to
25% in healthy women, depending on the
classification criteria applied. Differently
from the vertebral fracture data, our non-
vertebral fracture findings are similar to those
reported in the literature. Again, the diag-
nostic criteria for appendicular fractures are
universal and do not depend much upon the
diagnostic methodology used.
It is also interesting to observe that the
average cumulative dose of corticosteroid
used in our patients was significantly higher
than that described for other populations,
especially in North America (8). At our cen-
ter, KT patients use immunosuppressive
therapy that includes prednisone, a calcineu-
rin inhibitor (cyclosporine or tacrolimus)
and an antimetabolite (azathioprine or my-
cophenolate mofetil). At the time the pa-
tients selected underwent KT, neither tacro-
limus nor mycophenolate mofetil or induc-
tion therapy with polyclonal or monoclonal
antibody preparations were easily available
in Brazil. The immunosuppressive protocol
consisted mainly of prednisone, cyclosporine
and azathioprine. This may explain the higher
glucocorticoid doses needed to avoid rejec-
tion in our patients. One year after KT, the
average daily dosage of prednisone for our
patients was 6.95 mg, high enough to have a
negative impact on bone homeostasis. At
pharmacological doses, glucocorticosteroids
inhibit osteoblastogenesis and bone forma-
tion and increase osteoblast apoptosis, lead-
ing to bone loss and fragility fractures. The
higher corticosteroid doses used by our pa-
tients could theoretically explain the higher
prevalence of osteoporosis and fragility frac-
tures in our sample.
The prevalence of low bone mass follow-
ing KT varies according to the population
studied; it tends, however, to be more pro-
nounced than that observed in the general
population (25). The KT men and women
studied here showed a similar bone loss
prevalence and had fractures with BMD val-
ues than those reported in the literature for
the general population (9,10,23,25), a fact
suggesting that factors other than BMD are
involved in fracture risk determination in
KT recipients. This observation also sug-
gests that the WHO criteria used to deter-
mine fracture risk should be revised to better
classify fracture risk in the KT population
(10,14,29). Another strategy to improve the
evaluation of fracture risk in KT patients
would be to establish absolute BMD values
below which fracture risk is significantly
higher. The singular bone disease following
KT could also explain the prevalence of
fractures with higher BMD values in this
population. Most patients developed bone
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disease related to renal failure before KT
(dialysis stage) and after it (immunosup-
pressive therapy). Thus, they could have a
bone disease pathologically different from
primary osteoporosis. Parker et al. (24),
studying bone histomorphometry in 38 KT
women, observed that only 2 of them had
normal results even when evaluated 8 years
after KT.
Most investigators studying skeletal fra-
gility in KT patients have analyzed men and
women together. In our study, men and
women were assessed separately and classi-
fied according to fracture status. In women,
diabetes mellitus, menopausal status, FN
BMD, cumulative dose of steroids, and low
SI were the most important determinants of
fracture risk. As observed in another study
(26), diabetes mellitus is a very important
risk factor for fractures in KT women (OR =
11.5, 95% CI = 2.4-55.7). A dynamic bone
disease and bone formation impairment re-
lated to peripheral resistance to PTH, have
both been observed in diabetic patients, lead-
ing to higher fracture risk in this population
(17). Moreover, other risk factors (steroids,
physical activity, IGF-1, stress fractures, ath-
erosclerosis) (24,30) could theoretically have
synergistic effects on bone loss in this sub-
group of patients. Menopause is one of the
main risk factors for fractures in healthy
women, as well as in KT patients (25). Inter-
estingly, Ramsey-Goldman et al. (12) re-
ported no statistically significant differences
in fracture prevalence between pre- and post-
menopausal KT women, but they only in-
vestigated symptomatic vertebral fractures.
In KT men, longer time of dialysis, lower
LS BMD, lower SI, and lower BMI were the
factors most significantly associated with
fractures. A longer duration of dialysis influ-
enced the occurrence of fractures, suggest-
ing that pre-transplantation bone disease is
an important determinant of future fractures.
Lower SI and bone density were associated
with fracture risk, as also reported by Pichette
et al. (10) and Parker et al. (24), who have
described vertebral fractures in men and have
shown a significant correlation between
lower LS BMD, lower SOS and fractures.
As previously noted by other authors,
there was a statistically significant correla-
tion between QUS measurements obtained
from the left and right heels (r = 0.84),
excluding the need for duplicate bilateral
QUS testing in routine practice (31,32).
Even though KT recipients had a higher
fracture prevalence than that reported for the
general population, the odds ratio described
in the present study are comparable to those
found in patients with postmenopausal os-
teoporosis or osteoporosis related to the ag-
ing process (33). These findings suggest that
bone mass measurements and specific clini-
cal factors can predict fractures in KT pa-
tients with the same performance as that
described for the general population.
Most of our patients had received a trans-
plant from living donor (54%) and one could
question whether our sample is representa-
tive of the Brazilian KT population. Accord-
ing to data from the Brazilian National Sys-
tem of Transplants, most of the organ trans-
plantation in our country is still from living
donors. Similar to our findings, repartition
transplantation from living donors versus
transplantation from cadaveric donors for
kidney transplantation in Brazil in the years
of 2003 and 2004 was 58.9 and 41.1% and
47.2 and 52.8%, respectively (24). At most
Brazilian transplantation centers there still is
a significantly high rate of allocation failure
for organs from cadaveric donors, a fact that
helps to explain the higher repartition rate
for living donor transplants compared to
cadaveric donors.
The present study has some limitations
that need to be pointed out. The cross-sec-
tional study design may have caused inher-
ent flaws in the data collection and pre-
vented the authors from determining the cor-
rect time when the vertebral deformities oc-
curred. Important details regarding rejection
episodes, oral calcium intake and mineral
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calcium metabolism before and after KT
were also not assessed in this study and may
have had a significant impact on fracture
determination.
We observed a high prevalence of low-
impact fractures in a young population of
kidney transplantation patients. Higher frac-
ture prevalence was found in postmenopausal
or diabetic women and in men with a longer
time of dialysis, lower FN BMD and lower
BMI. In addition, BMD and QUS measure-
ments showed a comparable performance in
distinguishing male and female patients with
fractures from those without after kidney
transplantation. Longitudinal studies are
needed to better quantify the influence of
these factors on fracture risk in this popula-
tion.
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